Individuals with nonvalvular atrial fibrillation (NVAF) are at a significantly elevated risk of ischemic stroke, heart failure, and mortality. Alarmingly, many cases of NVAF remain undiagnosed in the United States, with pronounced disparities in detection based on socioeconomic status and race/ethnicity. To mitigate this burden, it is crucial for healthcare providers to adopt the latest guideline recommendations, including the new NVAF staging framework, and implement evidence-based strategies for lifestyle and risk factor modification to improve patient outcomes and reduce complications. Join us for an expert-led discussion, featuring prominent leaders in cardiology and primary care. This program will present a comprehensive approach to reducing NVAF-related stroke risk through early detection, risk stratification, and proactive patient management. Attendees will gain valuable insights into the most up-to-date guidelines and practical strategies to enhance outcomes and address the growing challenge of undiagnosed NVAF.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/uncovering-atrial-fibrillation-identifying-risks-enhancing-detection
- Start Date: 2024-11-18 06:00:00
- End Date: 2024-11-18 06:00:00
- Credit Details: AAPA Category 1 Credit™️: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours
Pharmacy: 0.25 hours - Commercial Support: Source: Bristol-Myers Squibb Company - Amount: 30000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all